Incidence, risk factors, and clinical characteristics of deep vein thrombosis following combined radiofrequency ablation and sclerotherapy for varicose veins
- 2 September 2025
- journal article
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 41 (5) , 394-401
Abstract
Objective: This study aims to investigate the incidence, risk factors, and clinical characteristics of deep vein thrombosis (DVT) following radiofrequency ablation (RFA) combined with sclerotherapy for varicose veins. Methods: A retrospective analysis was conducted on patients who underwent combined RFA and sclerotherapy between June 2018 and June 2024. The incidence of postoperative DVT and its clinical characteristics were evaluated, with 13 potential risk factors assessed through univariate and multivariate logistic regression. Patients with distal DVT were divided into two groups: Group A (treatment with prophylactic-dose anticoagulation) and Group B (no anticoagulation), with thrombus resolution outcomes compared between the groups. Results: Among 567 patients with varicose veins, including 226 males and 341 females (male-to-female ratio 1:1.51), with a mean age of 57.79 ± 11.38 years (range: 28–77 years), postoperative DVT occurred in 46 patients (8.11%), 36 of whom (78.26%) were diagnosed within 3 days. Thrombosis predominantly affected the muscular veins and posterior tibial veins (91.30%). Multivariate analysis identified a history of thrombosis, injection volume >10 mL of foam, and injection sites distal to the ankle joint as independent risk factors for DVT. Furthermore, Group A demonstrated a significantly lower prevalence of thrombosis at each time point compared to Group B ( p < .05). Conclusion: The incidence of postoperative DVT following combined RFA and foam sclerotherapy for varicose veins is relatively high, with the majority occurring in the early postoperative period. Thrombosis primarily affects the muscular and posterior tibial veins. A history of thrombosis, injection volume >10 mL of foam, and injection sites distal to the ankle joint are independent risk factors. Prophylactic-dose anticoagulation therapy may facilitate thrombus resolution in patients with distal DVT.Keywords
Funding Information
- Natural Science Foundation of Chongqing Municipality (CSTB2023NSCQ-MSX0723)
This publication has 26 references indexed in Scilit:
- Calciprotein particle-activated endothelial cells aggravate smooth muscle cell calcification via paracrine signallingCellular and Molecular Life Sciences, 2025
- The anterior saphenous vein. Part 2. Anatomic considerations in normal and refluxing patients. Endorsed by the American Vein and Lymphatic Society, the American Venous Forum, and the International Union of PhlebologyJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2024
- Strategies to reduce rates of severe endothermal heat-induced thrombosis following radiofrequency ablationJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2024
- Sclerotherapy in the treatment of varicose veinsDie Dermatologie, 2020
- Assessment of thrombotic adverse events and treatment patterns associated with varicose vein treatmentJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2015
- Radiofrequency ablation: an assessment of clinical and cost efficacyIrish Journal of Medical Science (1971 -), 2014
- The incidence and characterization of deep vein thrombosis following ultrasound-guided foam sclerotherapy in 1000 legs with superficial venous refluxJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2013
- In Vivo Biological Effects of Foam SclerotherapyEuropean Journal of Vascular and Endovascular Surgery, 2011
- Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous refluxJournal of Vascular Surgery, 2010
- Chronic Venous Disease Treated by Ultrasound Guided Foam SclerotherapyEuropean Journal of Vascular and Endovascular Surgery, 2006